Clinuvel Pharmaceuticals Statistics
Total Valuation
CUVL has a market cap or net worth of $354.78 million. The enterprise value is $191.90 million.
| Market Cap | 354.78M |
| Enterprise Value | 191.90M |
Important Dates
The next estimated earnings date is Friday, August 28, 2026.
| Earnings Date | Aug 28, 2026 |
| Ex-Dividend Date | Sep 8, 2025 |
Share Statistics
CUVL has 50.16 million shares outstanding. The number of shares has increased by 0.37% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 50.16M |
| Shares Change (YoY) | +0.37% |
| Shares Change (QoQ) | +0.25% |
| Owned by Insiders (%) | 7.55% |
| Owned by Institutions (%) | 22.72% |
| Float | 43.88M |
Valuation Ratios
The trailing PE ratio is 16.35 and the forward PE ratio is 13.58.
| PE Ratio | 16.35 |
| Forward PE | 13.58 |
| PS Ratio | 5.52 |
| Forward PS | 3.59 |
| PB Ratio | 2.14 |
| P/TBV Ratio | 2.14 |
| P/FCF Ratio | 12.61 |
| P/OCF Ratio | 13.14 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.59, with an EV/FCF ratio of 6.82.
| EV / Earnings | 8.84 |
| EV / Sales | 2.99 |
| EV / EBITDA | 6.59 |
| EV / EBIT | 6.69 |
| EV / FCF | 6.82 |
Financial Position
The company has a current ratio of 14.64, with a Debt / Equity ratio of 0.00.
| Current Ratio | 14.64 |
| Quick Ratio | 13.98 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.01 |
| Debt / FCF | 0.01 |
| Interest Coverage | 8.53 |
Financial Efficiency
Return on equity (ROE) is 13.96% and return on invested capital (ROIC) is 193.72%.
| Return on Equity (ROE) | 13.96% |
| Return on Assets (ROA) | 10.62% |
| Return on Invested Capital (ROIC) | 193.72% |
| Return on Capital Employed (ROCE) | 17.07% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $4.01M |
| Profits Per Employee | $1.36M |
| Employee Count | 16 |
| Asset Turnover | 0.38 |
| Inventory Turnover | 1.12 |
Taxes
In the past 12 months, CUVL has paid $7.78 million in taxes.
| Income Tax | 7.78M |
| Effective Tax Rate | 26.38% |
Stock Price Statistics
The stock price has increased by +3.06% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +3.06% |
| 50-Day Moving Average | 6.86 |
| 200-Day Moving Average | 7.45 |
| Relative Strength Index (RSI) | 58.45 |
| Average Volume (20 Days) | 5,885 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CUVL had revenue of $64.24 million and earned $21.70 million in profits. Earnings per share was $0.43.
| Revenue | 64.24M |
| Gross Profit | 57.58M |
| Operating Income | 28.68M |
| Pretax Income | 29.48M |
| Net Income | 21.70M |
| EBITDA | 29.13M |
| EBIT | 28.68M |
| Earnings Per Share (EPS) | $0.43 |
Balance Sheet
The company has $155.42 million in cash and $216,011 in debt, with a net cash position of $155.20 million or $3.09 per share.
| Cash & Cash Equivalents | 155.42M |
| Total Debt | 216,011 |
| Net Cash | 155.20M |
| Net Cash Per Share | $3.09 |
| Equity (Book Value) | 166.10M |
| Book Value Per Share | 3.31 |
| Working Capital | 162.44M |
Cash Flow
In the last 12 months, operating cash flow was $26.99 million and capital expenditures -$260,256, giving a free cash flow of $28.13 million.
| Operating Cash Flow | 26.99M |
| Capital Expenditures | -260,256 |
| Depreciation & Amortization | 476,497 |
| Net Borrowing | -140,717 |
| Free Cash Flow | 28.13M |
| FCF Per Share | $0.56 |
Margins
Gross margin is 89.63%, with operating and profit margins of 44.65% and 33.79%.
| Gross Margin | 89.63% |
| Operating Margin | 44.65% |
| Pretax Margin | 45.90% |
| Profit Margin | 33.79% |
| EBITDA Margin | 45.36% |
| EBIT Margin | 44.65% |
| FCF Margin | 43.79% |
Dividends & Yields
This stock pays an annual dividend of $0.03, which amounts to a dividend yield of 0.36%.
| Dividend Per Share | $0.03 |
| Dividend Yield | 0.36% |
| Dividend Growth (YoY) | -11.84% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 6.14% |
| Buyback Yield | -0.37% |
| Shareholder Yield | -0.01% |
| Earnings Yield | 6.12% |
| FCF Yield | 7.93% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | 11.62% |
| EPS Growth Forecast (3Y) | 10.42% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CUVL has an Altman Z-Score of 18.96 and a Piotroski F-Score of 4.
| Altman Z-Score | 18.96 |
| Piotroski F-Score | 4 |